Unraveling obscurins in heart disease

作者: Alyssa Grogan , Aikaterini Kontrogianni-Konstantopoulos

DOI: 10.1007/S00424-018-2191-3

关键词: Hypertrophic cardiomyopathyCardiomyopathyBioinformaticsDiseaseHeart failureFrameshift mutationMissense mutationDilated cardiomyopathyBiologyHeart disease

摘要: Obscurins, expressed from the single OBSCN gene, are a family of giant, modular, cytoskeletal proteins that play key structural and regulatory roles in striated muscles. They were first implicated development heart disease 2007 when two missense mutations found patient diagnosed with hypertrophic cardiomyopathy (HCM). Since then, discovery over dozen missense, frameshift, splicing linked to various forms cardiomyopathy, including HCM, dilated (DCM), left ventricular non-compaction (LVNC), has highlighted as potential disease-causing gene. At this time, functional consequences identified remain largely elusive, much work yet be done characterize mechanisms pathological variants. Herein, we describe known date, discuss their impact on development, provide future directions order better understand involvement obscurins disease.

参考文章(76)
Adam Pleister, Randell K Wexler, David Feldman, Terry Elton, Cardiomyopathy: an overview. American Family Physician. ,vol. 79, pp. 778- 784 ,(2009)
Steven Marston, Cecile Montgiraud, Alex B. Munster, O’Neal Copeland, Onjee Choi, Cristobal dos Remedios, Andrew E. Messer, Elisabeth Ehler, Ralph Knöll, OBSCN Mutations Associated with Dilated Cardiomyopathy and Haploinsufficiency PLOS ONE. ,vol. 10, ,(2015) , 10.1371/JOURNAL.PONE.0138568
Nicole A Perry, Michele I Vitolo, Stuart S Martin, Aikaterini Kontrogianni-Konstantopoulos, None, Loss of the obscurin-RhoGEF downregulates RhoA signaling and increases microtentacle formation and attachment of breast epithelial cells Oncotarget. ,vol. 5, pp. 8558- 8568 ,(2014) , 10.18632/ONCOTARGET.2338
Aikaterini Kontrogianni-Konstantopoulos, Maegen A. Ackermann, Amber L. Bowman, Solomon V. Yap, Robert J. Bloch, Muscle Giants: Molecular Scaffolds in Sarcomerogenesis Physiological Reviews. ,vol. 89, pp. 1217- 1267 ,(2009) , 10.1152/PHYSREV.00017.2009
Maide Ö. Raeker, Ashley N. Bieniek, Alison S. Ryan, Huai-Jen Tsai, Katelin M. Zahn, Mark W. Russell, Targeted deletion of the zebrafish obscurin A RhoGEF domain affects heart, skeletal muscle and brain development Developmental Biology. ,vol. 337, pp. 432- 443 ,(2010) , 10.1016/J.YDBIO.2009.11.018
Andrei B Borisov, Maide O Raeker, Aikaterini Kontrogianni-Konstantopoulos, Kun Yang, David M Kurnit, Robert J Bloch, Mark W Russell, Rapid response of cardiac obscurin gene cluster to aortic stenosis: differential activation of Rho-GEF and MLCK and involvement in hypertrophic growth Biochemical and Biophysical Research Communications. ,vol. 310, pp. 910- 918 ,(2003) , 10.1016/J.BBRC.2003.09.035
Davide Randazzo, Emiliana Giacomello, Stefania Lorenzini, Daniela Rossi, Enrico Pierantozzi, Bert Blaauw, Carlo Reggiani, Stephan Lange, Angela K. Peter, Ju Chen, Vincenzo Sorrentino, Obscurin is required for ankyrinB-dependent dystrophin localization and sarcolemma integrity Journal of Cell Biology. ,vol. 200, pp. 523- 536 ,(2013) , 10.1083/JCB.201205118
Ray E. Hershberger, Dale J. Hedges, Ana Morales, Dilated cardiomyopathy: the complexity of a diverse genetic architecture Nature Reviews Cardiology. ,vol. 10, pp. 531- 547 ,(2013) , 10.1038/NRCARDIO.2013.105
Ellen G Vernon, Karim Malik, Paul Reynolds, Rachel Powlesland, Anthony R Dallosso, Sally Jackson, Karla Henthorn, Eric D Green, Keith W Brown, The parathyroid hormone-responsive B1 gene is interrupted by a t(1;7)(q42;p15) breakpoint associated with Wilms' tumour Oncogene. ,vol. 22, pp. 1371- 1380 ,(2003) , 10.1038/SJ.ONC.1206332